相关实验视频
Updated: Jul 15, 2025
08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
16.3K
慢性病患者的心力衰竭
Andrew Xanthopoulos1, Adamantia Papamichail2, Alexandros Briasoulis2
1Department of Cardiology, University Hospital of Larissa, 41110 Larissa, Greece.
Journal of clinical medicine
|September 28, 2023
概括
心脏和脏疾病紧密联系在一起,创造了一个负面的螺旋. 慢性病中心力衰竭的管理是复杂的,因为药物相互作用和患者的风险.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心脏病学 心脏病学
- 内部医学 内部医学
背景情况:
- 心脏和脏有着相互关系,其中一个器官的功能障碍可以加速或加剧另一个器官的疾病.
- 糖尿病,高血压和动脉样硬化等常见疾病加剧了这种心脏与脏的相互作用.
- 慢性病 (CKD) 通过改变血液动力学和水分保留影响心脏功能,导致心力衰竭 (HF).
研究的目的:
- 审查慢性病患者心力衰竭 (HF) 的流行病学,病理生理学和当前医疗管理.
主要方法:
- 本综述综合了有关心脏脏综合征的现有文献,重点关注CKD背景下的HF.
- 它检查了由于功能改变而导致的高炎药物的管理所面临的挑战,反之亦然.
- 该审查还考虑了该患者群体中贫血和高胆固醇血症的风险增加.
主要成果:
- 患有严重功能障碍 (eGFR ≤ 30 mL/min/1.73 m2) 的患者通常被排除在心力衰竭临床试验之外.
- 在CKD中治疗HF是复杂的,因为这两种疾病及其治疗之间的复杂相互作用.
- 药物新陈代谢的改变和高血压药物对功能潜在的不良影响带来了重大挑战.
结论:
- 心脏和脏轴是管理心脏和脏疾病患者的关键考虑因素.
- 对于CKD中HF的有效管理策略,需要对病理生理学和治疗复杂性的全面了解.
- 进一步的研究和临床试验纳入标准需要解决患有同时存在HF和CKD的患者的独特需求.
相关概念视频
01:18Chronic Kidney Disease IV: Nursing Management
11
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
11
01:22Heart Failure Drugs: Diuretics
412
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
412
01:25Chronic Kidney Disease I: Introduction
20
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
20
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
454
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
454
01:22Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K